Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…KEEPsAKE 2 pooled for prespecified outcomes. Outcomes measuring risankizumab efficacy across key GRAPPA-recognised domains of PsA (periphera…
…Samson CM. Immunosuppressant-associated eruptions in paediatric inflammatory bowel disease: a case-control study. Journal article. 2022.Cossio ML, Genois …
…om hospital correspondence, see figure 1 for options) Q2: Which amyloidosis diagnosis is assigned in the GP-held record? (coded by GPs usin…
…blockers, amiodarone, flecainide, calcium channel blockers, and digoxin, which are commonly prescribed for rhythm management in these p…
…in K, Khoo C, Wilson D. Management of hyperlipidaemia following acute coronary syndrome: a retrospective audit. Br J Cardiol 2021;28:62–66.Cardiovascul…
…nd in combination with pembrolizumab, across heavily pretreated advanced solid tumors in the ARTISTRY-1 study. We report in-depth antitumor activity,…
…e. No patient from the idiopathic iTTP group developed clinical SLE during follow-up.Conclusion Patients with iTTP are prone to dev…
…, and functional dependency (28.1% vs 22.8%, p=0.37).Conclusion TNK and tPA demonstrated comparable safety and mortality in BAO tre…
…5.06% (Medina), 94.78% (Nautilus), 87.37% (Trenza), and 89.08% (Neqstent), but estimates were based on smaller evidence bases and shorte…
…remission and mucosal healing by September 2024, at which point mesalamine was discontinued. Concomitantly, at diagnosis, blood tests show…
…ts. Our study aims to explore the mechanisms of LMWH on chronic colitis-associated intestinal fibrosis, focusing on gut microbiota and its metabol…